Results 161 to 170 of about 2,198,023 (191)
Some of the next articles are maybe not open access.
Is Diarrhea Predominant Irritable Bowel Syndrome (IBS-D) a Myth?
Medical Research Archives, 2022The prevalence of Diarrhea Predominant Irritable Bowel Syndrome (IBS D) and chronic diarrhea has been one of the most troublesome diagnoses inflicting approximately 5% of the population annually. These entities have always perplexed physicians that attempt to offer relief to millions of sufferers. Because of the magnitude of the problem, physicians and
openaire +1 more source
Current and future pharmacological treatments for diarrhea-predominant irritable bowel syndrome
Expert Opinion on Pharmacotherapy, 2013Diarrhea-predominant irritable bowel syndrome (IBS-D) affects about one-third of patients with IBS, which is observed in about 12% of people across five continents. The ultimate goal in this field is to identify the underlying cause of symptoms in order to individualize education of the patient, and to provide optimal treatment of this highly prevalent
openaire +2 more sources
Diarrhea Predominant Irritable Bowel Syndrome (IBS-D): Fact or fiction
Medical Hypotheses, 2011Diarrhea Predominant Irritable Bowel Syndrome IBS (IBS-D) and functional diarrhea constitute 50% of cases treated by gastroenterology specialists and a significant proportion of those treated in a primary physicians practice. The size of the problem and the difficulty in successfully addressing these entities has frustrated patients and physicians ...
openaire +2 more sources
DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME
American Journal of Gastroenterology, 2004George J. Wan +2 more
openaire +1 more source
Commentary: The reintroduction of Lotronex for diarrhea-predominant irritable bowel syndrome
BMJ, 2003From BMJ USA 2002;Nov:637 The Food and Drug Administration approves program to provide patient access and manage risk Immediately after the November 28, 2000 announcement of the safety-related withdrawal of Lotronex, distraught patients, stunned that this therapy had been taken away from them, began to contact the Food and Drug Administration (FDA).
openaire +1 more source
Undiagnosed Exocrine Pancreatic Insufficiency in Diarrhea-Predominant Irritable Bowel Syndrome
Digestive Diseases and Sciences, 2022Alice A, Lee, Julia, McNabb-Baltar
openaire +2 more sources

